Historical award
Emergent Biodefense Operations Lansing LLC
This record is historical buying context, not open work.
How current is this award history?
Fiscal year 2025: data through (15 days old).
Fiscal year 2026: data through (15 days old).
Official release availability details
Fiscal year 2025: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
Fiscal year 2026: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
- Current award value
- $213,770,068.00
- Potential award value
- $649,849,467.00
- Total obligated to date
- $213,770,068.00
Source date: Nov 9, 2026
Recorded work
NO COST MOD TO EXTEND THE POP FOR CLIN0001 THROUGH AUGUST 28, 2031. EXERCISE AND FULLY FUND OPT CLIN0005B FOR THE PROCUREMENT OF 4,896 ORAL SUSPENSION TREATMENT COURSES IN THE AMOUNT OF $2,360,280.00. UPDATE G.1. CO. UPDATE G.3. CONTRACTOR'S POI
Award activity
- Obligations in covered fiscal years
- $19,464,480.00
- Transactions in covered fiscal years
- 4
Award value and obligated funds describe different amounts. Review the official record for the full transaction history.
Record identifier
CONT_AWD_75A50122C00047_7505_-NONE-_-NONE-